259 related articles for article (PubMed ID: 15813810)
1. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
2. Rush immunotherapy with sublingual administration of grass allergen extract.
Feliziani V; Marfisi RM; Parmiani S
Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
[TBL] [Abstract][Full Text] [Related]
3. Nasal immunotherapy in weed-induced allergic rhinitis.
Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
[TBL] [Abstract][Full Text] [Related]
4. [Sublingual specific immunotherapy for rhinoconjunctivitis caused by grass pollens].
Sabbah A; Lesellin J; Hassoun S; Sicard H; André C
Allerg Immunol (Paris); 1993 Jun; 25(6):241-7. PubMed ID: 8357473
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with alginate-conjugated two grass pollen extract in patients with allergic rhinoconjunctivitis.
Tari MG; Mancino M; Pozzuoli G; Mauro B; Verga A; Monti G
Allergol Immunopathol (Madr); 1990; 18(1):35-40. PubMed ID: 2382596
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study.
Feliziani V; Lattuada G; Parmiani S; Dall'Aglio PP
Allergol Immunopathol (Madr); 1995; 23(5):224-30. PubMed ID: 8526180
[TBL] [Abstract][Full Text] [Related]
7. Allergen-induced changes of B-cell phenotypes in patients with allergic rhinitis.
Davidsson A; Karlsson MG; Hellquist HB
Rhinology; 1994 Dec; 32(4):184-90. PubMed ID: 7535471
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of specific IgE, soluble interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in seasonal allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Sakamoto H; Kato A; Washio Y; Hayashi M
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):213-20. PubMed ID: 9305226
[TBL] [Abstract][Full Text] [Related]
9. Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation.
Godthelp T; Fokkens WJ; Kleinjan A; Holm AF; Mulder PG; Prens EP; Rijntes E
Clin Exp Allergy; 1996 Jun; 26(6):677-88. PubMed ID: 8809425
[TBL] [Abstract][Full Text] [Related]
10. [Oral immunotherapy in oculorhinitis from Gramineae].
Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
Recenti Prog Med; 1996 Jan; 87(1):4-6. PubMed ID: 8711254
[TBL] [Abstract][Full Text] [Related]
11. Increase in CD4+ and CD45RO+ memory T cells in the nasal mucosa of allergic patients.
Karlsson MG; Davidsson A; Hellquist HB
APMIS; 1994 Oct; 102(10):753-8. PubMed ID: 7826604
[TBL] [Abstract][Full Text] [Related]
12. [The effect of fluticasone propionate topically dosed prior to the pollen scattering season on cellular infiltration into the surface of nasal mucous membrane in patients with Japanese cedar pollinosis].
Onishi M; Suihou X; Okubo K; Ikeda M; Yokoshima K; Okuda M
Arerugi; 1993 Mar; 42(3 Pt 1):228-35. PubMed ID: 8498894
[TBL] [Abstract][Full Text] [Related]
13. [Reproducibility and seasonal dependence of specific intranasal provocation tests in birch pollen allergy patients].
Klimek L; Reichenbach M; Mewes T; Mann W
Laryngorhinootologie; 1997 Aug; 76(8):475-9. PubMed ID: 9376030
[TBL] [Abstract][Full Text] [Related]
14. Two-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis.
Nuutinen J; Ruoppi P; Sorri M; Suonpää J; Vainio-Mattila J
Rhinology; 1983 Jun; 21(2):165-72. PubMed ID: 6351231
[TBL] [Abstract][Full Text] [Related]
15. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
[TBL] [Abstract][Full Text] [Related]
16. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.
Ciprandi G; Tosca M; Ricca V; Passalacqua G; Riccio AM; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1160-6. PubMed ID: 9383256
[TBL] [Abstract][Full Text] [Related]
17. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy.
Håkansson L; Heinrich C; Rak S; Venge P
J Allergy Clin Immunol; 1997 Apr; 99(4):551-62. PubMed ID: 9111502
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized study investigating the efficacy and specificity of immunotherapy with Artemisia vulgaris or Phleum pratense/betula verrucosa.
Olsen OT; Frølund L; Heinig J; Jacobsen L; Svendsen UG
Allergol Immunopathol (Madr); 1995; 23(2):73-8. PubMed ID: 8526170
[TBL] [Abstract][Full Text] [Related]
19. Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients.
Woschnagg C; Rak S; Venge P
Clin Exp Allergy; 1996 Sep; 26(9):1064-72. PubMed ID: 8889262
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study of preventive immunotherapy with E.P.D., in the treatment of seasonal allergic disease.
Di Stanislao C; Di Berardino L; Bianchi I; Bologna G
Allerg Immunol (Paris); 1997 Feb; 29(2):39-42. PubMed ID: 9084819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
